Syensqo Initiates Strategic Review of its Performance & Care Segment (€2B)
Syensqo announces the initiation of a strategic review of its Performance & Care segment, as part of its commitment to focus on positioning as a pure player in specialty materials and advanced technologies. This move is part of a broader reflection on accelerating growth and enhancing value creation.
Redefining the Strategic Direction of the Group
Syensqo is committed to evaluating a range of strategic options for the Performance & Care segment, which includes the Novecare and Technology Solutions activities. The stated goal is to maximize long-term value creation for shareholders by refining the portfolio and refocusing on technologies with the highest growth potential.
This direction aligns with the group's intention to become a specialized pure player in specialty materials and advanced technologies, with increased exposure to structurally attractive markets such as aerospace and defense, electronics, healthcare, energy, and advanced mobility applications.
Scope and Details of the Reviewed Segment
The Performance & Care segment, consisting of the global business units Novecare and Technology Solutions, is a global leader in surface chemistry solutions and specialty mining reagents. It serves markets in personal care, agriculture, coatings, and mining extraction. In 2025, this segment generated a net revenue of €2.0 billion and an underlying EBITDA of €358 million.
The group has not set a precise timetable for this strategic review. There can be no assurance that this process will result in a transaction, nor on the terms or structure of any potential operation.
